Home > Insider Trading > Filing (0000904454-14-000518)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1314102	Psivida Corp.	PSDV	Laboratory Analytical Instruments (3826)	262774444

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1410291	Lori Freedman	C/O Psivida Corp. 480 Pleasant Street Watertown MA 02472	Vp Corp. Affairs, Gc And Sec	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-06-12	9,600	$1.81	106,023	No	4	M	Direct
Common Stock	Disposition	2014-06-12	9,600	$4.02	96,423	No	4	S	Direct
Common Stock	Acquisiton	2014-06-13	2,100	$1.81	98,523	No	4	M	Direct
Common Stock	Disposition	2014-06-13	2,100	$4.01	96,423	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-06-12	9,600	$0.00	9,600	$1.81
Common Stock	Srock Option (Right to Buy)	Disposition	2014-06-13	2,100	$0.00	2,100	$1.81

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
81,900		2019-06-25	No	4	M	Direct
79,800		2019-06-25	No	4	M	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.
The option was granted on 06/25/2009 and vested in four equal annual installments beginning on the first anniversary of the date of grant.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.